The North America Cardiac Monitoring & Cardiac Rhythm Management Devices Market is witnessing robust growth, driven by increasing prevalence of cardiovascular diseases, rapid advances in medical technology, and growing adoption of remote patient monitoring. With the market valued at USD 9,600 Million in 2025, it is projected to reach USD 18,900 Million by 2035, growing at a CAGR of 6.8% from 2024 to 2035.
The economic impact of tariffs on "North America Cardiac Monitoring & Cardiac Rhythm Management Devices Market".
Market Growth Drivers
Increasing Prevalence of Cardiovascular Diseases: The rise in cases of cardiovascular diseases in North America fuels demand for advanced cardiac monitoring and rhythm management devices. According to Abbott Laboratories, the growing geriatric population and lifestyle-related risk factors like obesity and diabetes have significantly contributed to a surge in cardiac conditions. This growing patient pool is prompting healthcare providers to adopt state-of-the-art monitoring devices, ensuring continuous patient management and timely interventions.
Technological Advancements and Product Innovation: Major players like Medtronic and Boston Scientific are significantly investing in research and development to introduce advanced cardiac monitoring solutions. Innovative products, such as leadless pacemakers and AI-powered remote cardiac monitors, offer enhanced accuracy and patient convenience. Medtronic's Micra™ Transcatheter Pacing System and Boston Scientific's LUX-Dx™ Insertable Cardiac Monitor exemplify the technological strides fostering market expansion, reducing complications, and enabling remote patient care.
Market Trends
Rising Adoption of Remote Monitoring & Telehealth: There is a notable trend towards remote monitoring and telemedicine, accelerated by the COVID-19 pandemic. Companies such as Philips and GE Healthcare are leveraging digital platforms that enable seamless data collection, transmission, and analysis. This ensures effective long-term monitoring of cardiac patients outside hospitals, reducing readmissions and facilitating evidence-based care, thereby reshaping the market landscape.
Integration of Artificial Intelligence and Data Analytics: The market is observing increased integration of AI and big data analytics within cardiac monitoring devices for predictive analytics and early intervention. For instance, BioTelemetry (Philips) has incorporated AI-driven arrhythmia detection algorithms into their wearable cardiac monitors, improving diagnostic accuracy. These data-centric solutions are becoming standard in patient management, providing actionable insights to clinicians and enhancing patient outcomes.
Market Opportunities
Expansion in Home Healthcare Segment: Companies like AliveCor are tapping into the growing home healthcare segment by developing portable and consumer-friendly cardiac monitoring solutions. The shift towards home-based cardiac care opens up significant new revenue streams, particularly among elderly and chronic patient populations.
Emergence of Wearable Cardiac Devices: The proliferation of smart wearable cardiac devices, such as smartwatches with ECG capabilities from Apple and Fitbit, presents vast market opportunities. These devices enable proactive health monitoring, early detection of anomalies, and improved patient engagement, ultimately expanding the target consumer base.
North America Cardiac Monitoring & Cardiac Rhythm Management Devices Market Revenue (USD Million), 2020-2035
The chart illustrates the progressive revenue growth of North America's Cardiac Monitoring & Cardiac Rhythm Management Devices Market from 2020 to 2035. In 2020, the market revenue stood at approximately USD 6,200 Million and witnessed steady growth, reaching USD 9,600 Million in 2025. This growth trend is projected to accelerate, driven by technological innovations, increased investments in healthcare infrastructure, and higher adoption of remote monitoring technologies. By 2035, the market is expected to nearly double, reaching USD 18,900 Million, signifying a CAGR of 6.8%. The consistent upward trajectory in the chart highlights strong market fundamentals fueled by rising cardiac health concerns and the introduction of next-generation monitoring solutions.
North America Cardiac Monitoring & Cardiac Rhythm Management Devices Market Share by Region (%), 2025
The pie chart displays the regional distribution of the North America Cardiac Monitoring & Cardiac Rhythm Management Devices Market for 2025. The United States dominates the market with 74% share, underpinned by its advanced healthcare infrastructure and higher adoption rates of innovative cardiac technologies. Canada follows with 17% due to growing investments in cardiac care and an increasing aging population. Mexico accounts for 6%, reflecting gradual market entry of advanced devices. The remaining 3% is attributed to other regions such as Puerto Rico and Bermuda. The chart underscores the strong leadership of the US market while spotlighting emerging growth in neighboring regions.
Recent Developments
In April 2024, Medtronic announced the launch of its latest CE-marked Reveal LINQ II™ Insertable Cardiac Monitor in North America, integrating remote programming and real-time data synchronization. This development enhances remote diagnostics and streamlines clinician workflow, delivering more actionable insights for patient management.
In March 2024, Abbott received FDA approval for its new Aveir™ DR Dual Chamber Leadless Pacemaker System. The launch marks the first dual-chamber leadless pacemaker in the US market, capable of delivering synchronized pacing to both chambers wirelessly. This breakthrough offers reduced procedural risks and expanded indications for complex arrhythmia cases.
In February 2024, Boston Scientific expanded its partnership with Apple to integrate Apple HealthKit with the LUX-Dx™ Insertable Cardiac Monitor platform. This collaboration aims to improve patient engagement by allowing data sharing between the monitor and Apple's health ecosystem. The seamless integration supports remote care initiatives and fosters long-term patient adherence in arrhythmia management programs.
Press Releases